Advertisement

Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis Patients

01:22 EDT 24th May 2013 | BioPortfolio

Summary

The primary objective of the study is to examine the risk of catheter dysfunction during the dialysis session that follows the instillation of ethanol 60% as lock solution in tunneled silicone catheters of end stage renal failure patients treated by hemodialysis.

The catheters dysfunction rate is the primary outcome. The dysfunction is defined as partial or complete occlusion or infection associated with dialysis catheter.

As a secondary outcome, the dialysis quality is also examined (urea reduction rate, total ultrafiltration)

Study Design

Intervention Model: Single Group Assignment, Primary Purpose: Treatment

Conditions

End Stage Renal Failure, Hemodialysis

Intervention

Ethanol

Location

Lacarin
Clermont-Ferrand
France
63000

Status

Terminated

Source

University Hospital, Clermont-Ferrand

Results (where available)

View Results

Links

Medical and Biotech [MESH] Definitions

Kidney Failure

A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal failure, either acute (KIDNEY FAILURE, ACUTE) or chronic (KIDNEY FAILURE, CHRONIC), requires HEMODIALYSIS.

Kidney Failure, Chronic

The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Renal Insufficiency, Chronic

Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)

Renal Insufficiency, Acute

Conditions in which the function of KIDNEYS deteriorates suddenly in a matter of days or even hours. It is characterized by the sudden drop in GLOMERULAR FILTRATION RATE; (GMR). The most severe stage is when the GFR drops below 15 ml per min (ACUTE KIDNEY FAILURE).

Kidney Failure, Acute

A severe stage of acute renal insufficiency, characterized by the sudden decrease in GLOMERULAR FILTRATION RATE to less than 15 ml per min, sometime to less than 1 to 2 ml per min. It is usually associated with OLIGURIA; EDEMA; and increase in BLOOD UREA NITROGEN and serum CREATININE concentrations.

Clinical Trials [ 1748 Associated Clinical Trials listed on BioPortfolio]

Effect of Zinc Suplementation on Serum Hemosystein Level in Hemodialysis Patients

The purpose of this study is to study the effect of zinc supplementation in end stage renal failure on hemocystein level.

Efficacy and Safety of Ethanol Lock Solution in Prevention of Catheter Related Bloodstream Infection for Patients Suffering Acute Renal Failure, and Hospitalized in Intensive Care Unit. A Multi-Center, Randomized, Versus Placebo, Double Blinded Clinical T

The primary objective of the study is to demonstrate the efficacy of 60% ethanol lock solution in preventing dialysis catheter related bloodstream infection in critically ill patients.

Oxidative Stress and Hemodialysis Access Failure

Complications of hemodialysis access are the most frequent single reason for hospitalization among patients with End Stage Renal Disease (ESRD). Uremia, and particularly uremia in patients...

Open-Label Study To Evaluate the Safety and Efficacy of the Renal Assist Device In Patients With Acute Renal Failure

Although conventional hemodialysis removes waste products and corrects fluid imbalance, it does not replace critical absorptive, metabolic, endocrine, and immunologic functions performed b...

Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)

The purpose of this research is to study the efficacy and safety of AMG 073 in patients with kidney failure who are being treated with hemodialysis or peritoneal dialysis and who also have...

PubMed Articles [ 15204 Associated PubMed Articles listed on BioPortfolio]

MRI for acute neurologic complications in end-stage renal disease patients on hemodialysis.

Acute cerebrovascular disease is one of the most frequent causes of mortality and morbidity in patients on long-term hemodialysis therapy. Early recognition of cerebrovascular events improves the prog...

Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study.

ABSTRACT: OBJECTIVE: To investigate the effects of hemodialysis (HD) and periotoneal dialysis (PD) on oxidative stress in chronic renal failure patients (CRF). Methods: 20 HD patients and 20 PD patien...

Hemodialysis in children with end-stage renal disease.

Although renal transplantation remains the most common treatment for children with end-stage renal disease (ESRD), the majority of children incident to ESRD receive dialytic therapy before receiving a...

Uremic Cardiomyopathy: An Underdiagnosed Disease.

Uremic cardiomyopathy is responsible for high morbidity and mortality rates among patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD); however, the early implementation of hem...

Evaluation of Multiple Myeloma Patients Presenting with Renal Failure in a University Hospital in the Year 2010.

Background: The aim of this cross-sectional study was to evaluate multiple myeloma patients presenting with renal failure in a University hospital. Methods: The records of all the patients diagnosed w...

More From BioPortfolio on "Catheters Dysfunction Rate After Instillation of Ethanol 60% Lock Solution in Tunneled Silicone Catheter of Chronic Hemodialysis Patients"

Search BioPortfolio: